- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 10-12-2025: Press Release
10-12-2025 | 10:14 am
10-12-2025 | 10:14 am
Zydus launched 'Zyrifa', a Denosumab biosimilar (120 mg SC) to protect bone health and treat metastases in cancer patients. Priced at Rs 12,495, this aims to improve patient access and affordability, supporting their fight against cancer.
No comments yet. Be the first to comment!